Sensei Biotherapeutics Inc [SNSE] stock prices are up 23.54% to $1.26 at the moment. It is a good measure of the stock’s recent performance to check whether the stock’s short-term value is rising or falling. The SNSE shares have gain 27.05% over the last week, with a monthly amount glided 27.27%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Sensei Biotherapeutics Inc [NASDAQ: SNSE] stock has seen the most recent analyst activity on July 01, 2021, when Berenberg downgraded its rating to a Hold but kept the price target unchanged to $12 for it. Previously, Oppenheimer downgraded its rating to Perform on June 29, 2021, and dropped its price target to $14. On March 01, 2021, Piper Sandler initiated with a Overweight rating and assigned a price target of $25 on the stock. Oppenheimer started tracking the stock assigning a Outperform rating and suggested a price target of $36 on March 01, 2021. Citigroup initiated its recommendation with a Buy and recommended $30 as its price target on March 01, 2021. Berenberg started tracking with a Buy rating for this stock on March 01, 2021, and assigned it a price target of $27.
The stock price of Sensei Biotherapeutics Inc [SNSE] has been fluctuating between $0.51 and $1.72 over the past year. Currently, Wall Street analysts expect the stock to reach $6 within the next 12 months. Sensei Biotherapeutics Inc [NASDAQ: SNSE] shares were valued at $1.26 at the most recent close of the market. An investor can expect a potential return of 376.19% based on the average SNSE price forecast.
Analyzing the SNSE fundamentals
Gross Profit Margin for this corporation currently stands at 0.45% with Operating Profit Margin at -13.02%, Pretax Profit Margin comes in at -11.98%, and Net Profit Margin reading is -11.55%. To continue investigating profitability, this company’s Return on Assets is posted at -0.44, Equity is -0.42 and Total Capital is -0.54. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.1.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 1.0575 points at the first support level, and at 0.8549 for the second support level. However, for the 1st resistance point, the stock is sitting at 1.3763, and for the 2nd resistance point, it is at 1.4925.
Sensei Biotherapeutics Inc [SNSE] reported earnings per share of -$0.3 for its fiscal quarter that ended on 12/31/2023. Based on the Wall Street analysts’ estimates, the company was expected to report earnings of -$0.31/share, meaning a difference of $0.01 and a surprise factor of 3.20%. By comparison, the stated earnings for the previous quarter ended on 9/30/2023 were -$0.28 per share as compared to estimates of -$0.34 per share, a difference of $0.06 representing a surprise of 17.60%.
Ratios To Look Out For
It’s worth pointing out that Sensei Biotherapeutics Inc [NASDAQ:SNSE]’s Current Ratio is 11.92. Further, the Quick Ratio stands at 11.92, while the Cash Ratio is 2.31.
Transactions by insiders
Recent insider trading involved Celebi John, President and CEO, that happened on Sep 11 ’23 when 500.0 shares were purchased. 10% Owner, Apeiron Investment Group Ltd. completed a deal on Jun 01 ’23 to sell 3.44 million shares.
